WATER-IN-OIL MICROEMULSIONS CONTAINING MEDIUM-CHAIN FATTY-ACIDS SALTS- FORMULATION AND INTESTINAL-ABSORPTION ENHANCEMENT EVALUATION

Purpose. Water-in-oil (w/o) microemulsions have been developed which, in addition to non-ionic medium-chain glycerides, incorporate ionic li pids, primarily medium-chain fatty acids, such as caprylic (C-8) capri c (C-10) and lauric (C-12) acids and their corresponding sodium salts. The absorption enhancing activity of w/o microemulsions incorporating these lipids was evaluated in the rat using Calcein (MW = 623) a wate r-soluble and poorly absorbed marker molecule. Methods. Phase diagrams were constructed where C-8/C-10 Or C-12 fatty acids were treated as l ipophilic surfactants and their sodium salts as hydrophilic ones. The anesthetised rat model was employed to evaluate Calcein absorption upo n a single intraduodenal administration from a solution and the variou s w/o microemulsions. Results. A wide range of clear and transparent w /o microemulsions were obtained at ambient temperature either in liqui d or solid form when a fixed blend of medium chain fatty acid/salt was titrated by a fixed ratio of the oil containing the oil-soluble mono- and diglycerides and deionized water or physiological saline. Upon in traduodenal administration in the anesthetised rat, the absorption of Calcein was improved from about 2% in aqueous solution up to about 37% in w/o microemulsions. Solid and liquid formulations were equally eff ective in improving bioavailability. The absorption enhancement activi ty of the fatty acids/salts followed the order C-8 approximate to C-10 > C-12 Absorption enhancement of Calcein was significantly reduced in the absence or presence of low levels of C-8/C-10 mono-/diglycerides. Conclusions. These results further support the use of medium-chain gl ycerides and fatty acids/salts in microemulsion formulations to improv e intestinal absorption of water-soluble compounds.